TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PharmaLogic Consulting AB
Closing information (x1000 SEK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
4,696
|
206 | |
| Financial expenses |
0
|
227 | |
| Earnings before taxes |
3,597
|
-1,220 | |
| EBITDA |
3,499
|
-994 | |
| Total assets |
10,181
|
8,855 | |
| Current assets |
8,506
|
7,221 | |
| Current liabilities |
1,194
|
336 | |
| Equity capital |
8,921
|
8,046 | |
| - share capital |
50
|
50 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
87.6%
|
90.9% | |
| Turnover per employee |
4,696
|
206 | |
| Profit as a percentage of turnover |
76.6%
|
-592.2% | |
| Return on assets (ROA) |
35.3%
|
-11.2% | |
| Current ratio |
712.4%
|
2149.1% | |
| Return on equity (ROE) |
40.3%
|
-15.2% | |
| Change turnover |
4,490
|
-2,532 | |
| Change turnover % |
-95%
|
2180%
|
-92% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.